Antibodies to phosphatidylcholine (PtC), a common constituent of mammalian and bacterial cell membranes, represent a large proportion of the natural antibody repertoire in mice. Previous studies of several mouse strains (e.g., C57BL͞6) have shown that anti-PtC antibodies are mainly encoded by the V H 11 and V H 12 immunoglobulin heavy chain variable region gene families. We show here, however, that V H 11 and V H 12 encode only a small proportion of the anti-PtC antibodies in BALB͞c mice. Instead, V H Q52-encoded antibodies predominate in this strain. In addition, two-thirds of the cells expressing V H Q52 family genes use a single gene (which, interestingly, has been previously shown to predominate in the anti-oxazolone response). We also show here that in anti-PtC antibodies from all strains, the distinctive antigen-binding sites associated with V H Q52 differ substantially from those associated with V H 11 and V H 12. That is, V H Q52-containing transcripts preferentially use the joining region J H 4 rather than J H 1 and exhibit more diverse complementarity-determining region 3 (CDR3) junctions with more N-region nucleotide additions at the gene segment junctions. Thus, the V H gene family that predominates in the anti-PtC repertoire differs among mouse strains, whereas the distinctive V H DJ H rearrangements (CDR3, J H ) associated with each V H gene family are similar in all strains. We discuss these findings in the context of a recent hypothesis suggesting that CDR3 structure, independent of V H framework, is sufficient to define the specificity of an antibody.
Consistent with the major role natural antibodies play in the innate defense against invading pathogens, antibodies to phosphatidylcholine (PtC, a ubiquitous membrane phospholipid found in both bacterial and mammalian membranes) have recently been shown to protect against acute peritonitis in a murine cecal ligation and puncture model (1) . B-1 cells, which produce many natural antibodies, are the sole producers of natural anti-PtC in the mouse (2, 3) . Cells producing these antibodies comprise 5-15% of B-1 cells in spleen and peritoneal cavity and bind to PtC on fluorochrome-containing liposomes (3, 4) . Thus, they are readily detectable by flow cytometry with a fluorescence-activated cell sorter (FACS) .
Previous studies have shown that anti-PtC antibodies are largely encoded by V H 11 and V H 12 in combination with the V 9 and V 4 light chains, respectively (5) (6) (7) (8) (9) (10) (11) . Other V H families, such as V H Q52, V H J558, and V H 7183, have been detected at very low frequencies (10, (12) (13) (14) . We have revisited this issue by sorting individual PtC-binding cells from several mouse strains and by using a single-cell reverse transcriptase (RT)-PCR method (with a promiscuous primer that amplifies V H genes from all V H families) to more precisely define the Ig heavy chain variable region sequences these cells express. Our findings agree with the predominance of V H 11 (5) (6) (7) (8) (9) (10) (11) 15) in C57BL͞6 mice and with the predominance of V H 12 in other mouse strains (we demonstrate it here in C.B-17). However, we surprisingly find that another gene family, V H Q52, predominates among anti-PtC in BALB͞c mice.
We consider the mechanisms underlying these strain differences elsewhere (J.A.W., K.J.S., and L.A.H., unpublished work) and focus here, instead, on comparison of the full rearrangement sequences [joining region (J H ) and diversity region (D) usage, N-region addition, etc.] of the large number of anti-PtC antibodies isolated in the course of these genetic studies.
Examination of these anti-PtC sequences demonstrates that each of the three variable region gene families has distinctive antigen-binding site characteristics. We show that anti-PtC antibodies encoded by the V H Q52 gene family are more diverse with respect to N-region addition and other complementarity-determining region 3 (CDR3) features than those encoded by V H 11 and V H 12 gene families. Furthermore, we show that V H Q52 is mainly associated with J H 4, whereas V H 11 and V H 12 are mainly associated with J H 1. This close association between V H gene family and CDR3 structure challenges the recently proposed idea that CDR3 structure per se is sufficient to define antibody specificity (16) . Thus, we discuss our findings in the context of this model as it applies to anti-PtC and other natural antibodies. FACS Reagents and Staining. Reagents, cell preparation, staining, and FACS sorting methods were described previously (17) . For single-cell sorting, cells were stained with fluorescein-encapsulated liposomes (PtC-liposomes) (3, 4, 15) , phycoerythrin-conjugated anti-IgM (331.12), and allophycocyanin-conjugated anti-CD5 (Ly-1, 53-7). Dead cells were excluded by propidium iodide. For FACS measurement of V H -family frequencies, cells were stained with PtC-liposomes, anti-V H 11 (V H 11Id.6e9)
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Single-Cell Sorting and Sequence Analyses. PtC-binding cells were first bulk-sorted either from individual C57BL͞6 and C.B-17 mice or from a pool of either 5 or 9 BALB͞c mice and then resorted to deposit individual cells into tubes for single-cell sequence analysis, and FACS phenotype information was collected for individually sorted cells. These methods, and methods used for RT-PCR amplification and sequencing of V H , and the sequence analysis software tools, have all been described (15, 20, 21) . Sequences were aligned to a germ-line database that we have assembled (A.B.K., J.D.M., K.J.S., and L.A.H., unpublished work).
Detection of Antibody Production by PtC-Binding Cells. Peritoneal cells pooled from 13 three-month-old BALB͞c female mice were stained with PtC-liposomes, anti-CD5, and anti-IgM (see above) and sorted on the basis of level of staining with PtC-liposomes. PtC-bright, -intermediate and -negative sorted populations and mock-sorted total peritoneal cells were put into culture in RPMI medium 1640 supplemented with 10% fetal calf serum, L-glutamine (290 g͞ml), penicillin (100 units͞ml), and streptomycin (70 g͞ml)) for 48 hr at a density of 10 6 cells per ml in the presence or absence of Salmonella typhosa lipopolysaccharide (LPS) (50 g͞ml). Sort purity was 98% for PtC-bright, 69% for PtC-intermediate, and 68% for PtC-negative cells. Cells were then resuspended at a concentration of 5 ϫ 10 6 cells per ml and tested for the ability to lyse bromelain-treated mouse erythrocytes (BrMRBC) in a complement-dependent plaquing assay (PFC) as previously described (22) .
RESULTS
Anti-PtC Antibodies in BALB͞c, C57BL͞6, and C.B-17 Use the Same V H Families, Although at Markedly Different Frequencies. Consistent with previous findings, our single-cell RT-PCR and sequencing studies show that anti-PtC antibodies in C57BL͞6 mice are predominantly V H 11-encoded (15) . Surprisingly, however, anti-PtCs from BALB͞c mice are predominantly encoded by the V H Q52 family (Fig. 1 Upper; Table  1 ). C.B-17 mice, which are congenic to BALB͞c but carry an IgH b chromosome region similar to C57BL͞6, show a third anti-PtC pattern: V H 12 predominates; V H 11 is common; and V H Q52 is rare. V H J558 family genes are used equally by all strains, at frequencies below the other three gene families. Despite these differences, representatives of each V H family are found among the anti-PtC antibodies in all strains (Fig. 1 , Table 1 ).
The V H gene frequencies in anti-PtC in the three strains are mirrored by data from multiparameter FACS studies in cells that were stained with fluorochrome-coupled monoclonal antibodies to V H 11 and V H 12 ( (Fig. 3) . D segment usage also differs among the families, with V H 11 and V H Q52 being more similar than V H 12 (Fig. 3) .
CDR3 Diversity. Most of the anti-PtC antibodies that have N-region additions at one or both junctions are encoded by V H Q52 genes, whereas V H 11 and V H 12 often have no insertions at all (Table 2; Fig. 4) . Consistent with this observation, V H Q52 CDR3 length is extremely heterogeneous, whereas V H 11 and V H 12 have homogeneous CDR3 lengths (Fig. 4) .
CDR3 Homology. The conserved CDR3 amino acid sequence (codons 95-102) in V H 11 and V H 12 anti-PtC differ as previously reported (18, 25) . V H Q52 sequences differ from those in either V H (Fig. 3 ) and may represent a PtC-binding motif. However, the amino acids conserved at these positions are not the same as those conserved among the V H Q52 (J H 4) sequences.
Comparison of derived amino acid sequences of the entire length of the V H J558, V H 11, V H 12 and V H Q52 germ-line genes (including the CDR1, CDR2 and FW regions) did not reveal any unexpected amino acid motifs shared among all PtCbinding antibodies.
Junctional Sequence Overlap. Sequences lacking N-region nucleotides often exhibit sequence overlap (homology) such that either coding end participating in a joint could have contributed the observed nucleotides at the joint. Consistent with this, V H 11 and V H 12 commonly lack N-region insertions ( Table 2 ) and tend to have more joints with sequence homology-e.g., of the V H 11 N-less sequences, two or more nucleotides of sequence overlap occurs at 68% (15͞22) of the V-D junction, and 70% (16͞23) of the D-J junctions.
DISCUSSION
Recent studies have shown directly that the innate production of antibodies to PtC plays a central role in protection against acute peritonitis in a murine cecal ligation and puncture model (1). These antibodies, which also react with PtC revealed on mouse erythrocyte membranes by protease treatment, are produced by B-1 cells that constitute a major fraction (5-15%) There is no significant difference between VH12 and VH11 for JH usage (Kruskal-Wallis, P ϭ 0.09). JH usage of VH11 and VH12 significantly differs from VHJ558 and VHQ52 (Kruskal-Wallis, P Ͻ 0.0002 for all combinations). The usage of VHQ52 and VHJ558 significantly differ from one another (P ϭ 0.02). ). Further, we introduce a third gene family to the anti-PtC repertoire, V H Q52, and show that it predominates among anti-PtCs in BALB͞c mice. However, despite this dramatic differential predominance, we find all three V H gene families represented among anti-PtCs in each strain. In addition, we find that each V H family is associated with a characteristic J H , D H , and CDR3 region regardless of whether it is the major or minor component of the anti-PtC repertoire in a particular strain. An earlier study identified V H Q52 as well as the other V H genes as components of the anti-PtC repertoire in BALB͞c mice (5) but examined the relative frequencies of these genes indirectly, by hybridoma analysis. This previous study failed to recognize the predominance of V H Q52 described here, either for methodological reasons or perhaps because the substrains of BALB͞c or the maintenance conditions of the mice differ from our own. The genetic, immune, and developmental mechanisms underlying the differential V H predominance that we observe will be considered elsewhere, in the context of evidence that bears directly on these issues. We report these finding here mainly to show that, in all strains, a given V H is typically associated with a characteristic CDR3 region.
Specifically, although V H representation in anti-PtC differs among mouse strains, in all strains we find that V H 11 and V H 12 anti-PtCs are mainly associated with J H 1 and with CDR3 regions that are homogeneous with respect to length. In contrast, V H Q52 in anti-PtC is mainly associated with J H 4 and with heterogeneous CDR3s that vary substantially in length. This finding suggests that, to be successful as PtC-binding antibodies, anti-PtC encoded by V H 11 and V H 12 must associate with substantially different J H and CDR3 structures than anti-PtC encoded by V H Q52.
Taken at face value, these findings conflict with a recent proposal by Davis et al. (16) that V H genes contribute very little to antibody specificity. These authors point out that the antigen-binding capabilities of the diverse CDR3 structures generated in association with a single V H should be sufficient, in combination with somatic mutation and antigen selection, to generate the entire range of antibody specificities in the murine repertoire. We do not disagree in principle; however, the selective association of V H and CDR3 structures in antiPtC that we have demonstrated suggests more complexity than this model allows.
This contradiction is readily resolved by recognizing that innate antibodies to antigens such as PtC must exist prior to antigen encounter and hence cannot necessarily rely on somatic mutation and selection as a means of defining specificity (for an antigen yet to be encountered). Thus, because B-1 cells are the primary producers of innate antibodies present in circulation (29) 
